Human coagulation factor Ⅷ (Shenzhen Weiguang Biological Products)

人凝血因子Ⅷ（深圳市卫光）

Report date: 2023/11/02 10:21:58

Base Information

Drug NameHuman coagulation factor Ⅷ (Shenzhen Weiguang Biological Products)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Non-recombinant coagulation factorBiologics > Blood components > Non-recombinant coagulation factor
Mechanisms of ActionCoagulation factor VIII replacementsCoagulation factor X stimulantsBlood coagulation pathway activation
TargetsCoagulation factor X
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsHemophilia A
Approved Indications in ChinaHemophilia A
Original Approved Country/TerritoryMainland China
Original Approved Date2023/10/27
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShenzhen Weiguang Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Weiguang Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A